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Abstract:- 
Four known secondary metabolites, namely Glochidonol (1), 3β,14β-dihydroxy-14β-
pregn-5-en-20-one (2), 3β-Hydroxystigmast-5-en-7-one (3), & Stigmasterol (4). The 
structures of these compounds were established by usual spectroscopic methods. This 
is the first report of 3β-Hydroxystigmast-5-en-7-one  from Caralluma  quadrangula 
stem.   
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Introduction:  
For thousands of years, medicinal plants have played an important role 
throughout the world in treating and preventing a variety of diseases.  The medically 
significant genus Caralluma is widely studied for its stem and fruits. It belongs to the 
family Asclepiadaceae, which comprises 200 genera and 2500 species (1). The genus 
Caralluma comprises about 200 species distributed throughout Africa and Asia. The 
majority of these species are indigenous to the Indian sub-continent and Arabian 
Peninsula (2). Certain species of Caralluma are edible and form part of the traditional 
medicine system of many countries (3). These are commonly used in folk medicine as 
remedies to treat wide variety of diseases and health conditions (4). C. arabica is 
traditionally used as an emollient and diuretic in United Arab of Emirates. It is also 
used to treat liver diseases, diabetes and hypertension. The flowers of C. arabica are 
applied externally for wounds and cuts, while the juice of the stem is given to sick 
people to speed convalescence of burns, itchy skin and sunburns (5,6). In the Indian 
state Andhra Pradesh, C. attenuata (Wight) is eaten raw as an antidiabetic agent, 
while the juice of the plant along with black pepper is recommended in the treatment 
of migraine (7). The diverse applications of Caralluma plants in folk medicine have 
prompted the phytochemical and biological investigations of their constituents (8). 
The key phytochemical ingredients in Caralluma are pregnane glycosides, flavone 
glycosides, megastigmane glycosides, bitter principles, triterpenes and saponins 
(9,10,11,12). 
Materials and Methods:-  
A..  General experimental procedures:-  
All chemicals were purified by following regular procedures [13,14] and all chemicals 
used Analytical Reagent grade. 
B.. Plant material:- 
  Stems a of Caralluma quadrangula  (Asclepiadaceae) were collected from Sana'a 
2014. The plant identified by Dr. Hessen Ibrahim. A voucher specimen of plant was 
deposited in Herbarium, Department of Phytochemistry. 
 C..  Extraction and Isolation:-  
Shade dried  stems were powdered and sieved. Afterwards the powder was stored in 
air tight container. The powder was weighed and extracted with soxhlet extractor by 
using solvents of polarity from non-polar end to polar end (Hexane, Chloroform, and 
Methanol) with successive solvent extraction. To concentrate the extracts and removal 
of final traces of solvent, rotary evaporate  was used [15,16]. Then, recrystallization 
 was done to purify the crude extracts. Melting point was taken by using Fisher-John 
apparatus. The 1H NMR and 13C NMR spectra were taken on Bruker 100 MHz and 
400 MHz, spectrometer, using an internal standard like TMS. Mass spectra were 
recorded by using ZAB-HS mass spectrometer.  
C..1. Test for alcohol:-   
Small amount of crude extract was dissolved in 0.5 ml of dioxane. The obtained 
solution was added to 0.5 ml of ceric ammonium nitrate reagent. Then about one ml 
of dioxane was added and shaken. Yellow to red color formation indicates the 
existence of an alcoholic hydroxyl group [17].  
C..2. Libermann-Burchard test:-  
Few drops of acetic anhydride were added to the extract and boiled. Concentrated 
sulphuric acid was added to the above cooled solution. Presence of sterols is 
confirmed from formation of a brown ring at the junction of two layers and green 
color in upper layer [17]. 
 C..3. General extraction and isolation:-  
The air-dried powder  (1100g) of stems of C. quadrangula  was extracted (Soxhlet) 
with solvents (3X, 8 hours each) and the combined extracts evaporated to give a 
brown gummy residue (6 g). This extract was subjected to silica gel flash column 
chromatography (FCC) with chloroform containing increasing percentages of 
methanol as eluent and each collected fraction was 20 ml. Fractions 1-5 were 
combined and rechromatographed by C.C. to yielded JJ1 (5.0 mg) identified as 
Glochidonol, (1),  (hexane-EtOAc), JJ2 (7.0 mg) identified as 3β,14β-dihydroxy-14β-
pregn-5-en-20-one (2),  JJ3 (7.8 mg) identified as 3β-Hydroxystigmast-5-en-7-one (3) 
& JJ5 (6.0 mg) identified as Stigmasterol  (4) . All the isolated compounds were 
identified by comparison with data from previous NMR and mass spectra. 
 Glochidonol (1). White powder (5.0 mg), mp 227-230 0C. 1H NMR (CDCl3, 300 
MHz): δ 4.71, 4,60 (2H, s, H-29a, b), 3.26 (1H, dd, J= 4.76, 11.00 Hz), 0.63, 0.65, 
0.80, 0.90, 0.94, 1.00, 1.10 (each 3H, s, Me×7). 13C NMR (CDCl3, 100 MHz): δ 
214.67 (C-3), 150.1 (C-20), 105.5 (C-29), 80.1 (C-1), 55.5 (C-5), 50.6 (C-9), 48.5 (C-
18), 48.1 (C-19), 43.2 (C-17), 43.0 (C-14), 41.0 (C-8), 40.2 (C-22), 39.0 (C-13), 
38.9(C-4), 37.3 (C-10), 35.8 (C-16), 34.5 (C-7), 30.0 (C-21), 28.2 (C-23), 27.6 (C-
15), 27.5 (C-12), 25.3 (C-2), 21.1 (C-11), 19.5 (C-30), 18.5 (C-6), 18.2 (C-28), 16.3 
(C-25), 16.2 (C-26), 15.6 (C-24), 14.7 (C-27). 
 
 
Fig.1.  Glochidonol 
 
3β,14β-dihydroxy-14β-pregn-5-en-20-one (2). Mp: 200 -201 0C. 1H-NMR (300 
MHz, CDCl3): δ 1.05 (3H s),  1.07 (3H s),  1.31 (3H, s),  1.45 (2H m), 1.50 (2H, m),  
1.54 (1H, m),  1.60 (1H m),  1.75, 1.8 (2H), 1.98 (2H, dd J1 =12.5; J2 = 5.5 Hz), 2.28 
(1H,q, J = 7.8Hz), 2.43 (2H, m), 3.7 (H, m, H-3), 4.12 (H, s, H-14) 5.16 (1H, s, H- 6). 
13C-NMR (75 MHz, CDCl3): δ 36.6  (C-1), 28.0 (C-2),  75.0 (C-3), 36.6 (C-4), 143.1 
(C-5),  121.9 (C-6),  36.1 (C-7), 53.2 (C-8),  50.4 (C-9), 36.5 (C-10), 25.3 (C-11), 
25.2 (C-12),  43.7 s, C-13),  78.1 ( s, C-14),  32.8  (C-15),  25.4 (C-16),  53.6 (s, C-
17), 15.5 (C-18), 15.3 (C-19), 121.5 (s, C-20),  30.1 (C-21). 
  
Fig.2. 3β,14β-dihydroxy-14β-pregn-5-en-20-one 
 
3β-Hydroxystigmast-5-en-7-one (3). Colorless granules from CHCl3/MeOH; mp: 
128 0C. EIMS m/z (rel. int.): 428 [M]+ (100), 410 (20), 395 (32), 287 (18), 247 (10), 
192 (30).  1H-NMR (300 MHz, CDCl3): δ 0.67 (3H, s, H-18), 1.17 (3H, s, H-19), 3.67 
(1H, m, H-3α), 5.69 (1H, d, J = 1.8 Hz, H-6). 13C-NMR (75 MHz, CDCl3): δ 36.28 (t, 
C-1), 31.16 (t, C-2), 70.52 (d, C-3), 41.78 (t, C-4), 166.10 (s, C-5), 124.23 (d, C-6), 
202.85 (s, C-7), 45.56 (d, C-8), 49.93 (d, C-9), 38.36 (s, C-10), 21.20 (t, C-11), 38.81 
(t, C-12), 43.08 (s, C-13), 49.93 (d, C-14), 26.54 (t, C-15), 28.11 (t, C-16), 54.48 (d, 
C-17), 11.94 (q, C- 18), 17.30 (q, C-19), 36.07 (d, C-20), 18.91 (q, C-21), 33.93 (t, C-
22), 26.35 (t, C-23), 45.87 (d, C-24), 29.69 (d, C-25), 18.76 (q, C-26), 19.79 (q, C-
27), 23.03 (t, C-28), 11.94 (q, C-29).  
 
Fig.3 3β-Hydroxystigmast-5-en-7-one 
 
 
Stigmasterol (4). 1H NMR ( 100 MHz, CDCl3): δ 0.82 (10H, q, J=7.19 Hz, Me-21γ, 
Me-26, Me-27, Me-29), 0.93 (1H, t, J=5.40 Hz Me-21β), 5.35 (1H, d, J=4.62 Hz, H-
22), 1.02 (8H, d, J=6.57 Hz , H-1α, 1β, Me-18, Me-19β, Me-19γ, Me-21α), 1.18 (6H, 
m, J=6.95 Hz 11β, H-12 β, H-12β, H-14, H-15 β, Me-19 β, H-28 β, H-28 β,), 5.15 
(1H, q, J=7.86 Hz, H-23), 1.46 (8H, m, J=5.91 Hz H-2 β, H-2 β, H-8, H-9, H-11α, H-
15 β, H-16 β, H-16 β), 1.67 (3H, d, J=10.35 Hz H-15α, H-17, H-25), 1.85 (2H, d, 
J=10.05 Hz, H7α, 7β),  2.03 (3H, m, J=8.07 Hz, 3-OH, H-20, H-24), 2.26 (2H, t, 
J=8.13 Hz, H-4α, 4β), 3.52 (1H, m, J=5.09 Hz H-3), 5.01 (1H, q, J=7.85 Hz H-6). 13C 
NMR (CDCl3): δ 12.20 (C-29), 12.33 (C-21), 19.10 (C-27), 20.10 (C-26), 21.25 (C-
19), 21.40 (C-18), 21.60 (C-11), 24.48 (C-16), 25.53 (C-15), 29.04 (C-28), 31.74 (C-
8), 32.01 (C-7), 32.01 (C-25), 32.01 (C-12), 36.62 (C-1), 37.38 (C-20), 39.8 (C-2), 
40.62 (C-10), 42.32 (C-13), 42.39 (C-9), 50.27 (C-4), 51.36 (C-14), 56.06 (C-24), 
56.98 (C-17), 71.88 (C-3), 121.8 (C-6), 129.38 (C-22), 138.44 (C-23), 140.86 (C-5).  
 
Fig.4. Stigmasterol 
 
Result and Discussion:-  
 Compound (1). is white powder. The 1H NMR spectrum showed seven tertiary 
methyl singlet's and one secondary hydroxyl group. It also showed olefinic  protons at 
δ 4.71 and 4.60. 13C NMR of the compound showed 30 signals for the terpenoid of 
lupine skeleton which was represented by seven methyl groups. The carbon bonded to 
the hydroxyl group C-1 appeared at δ 80.1, while the alkenic carbons appeared at δ 
149.1 and 105.5. 
Compound (2). Was isolated as white needle-like crystals, mp 200-2010C. The mass 
spectral data of the compound gave a molecular formula C21 H32O, m/z 412 M
+. 1H-
NMR showed signals for three angular methyl singlet's at δ 1.05, 1.07 and 1.31.  
The proton of H-3 appeared as a multiplet at δ 3.53 and singlet at δ 4.12. It also 
showed olefinic protons at δ 5.16. 13C NMR showed twenty one carbon signal 
including three methyles, nine methylenes, five methins and five quaternary carbons. 
The alkenes carbons appeared at δ 143.1 and 121.9. The significant signal for the 
3β,14β-dihydroxy-14β-pregn-5-en-20-one would be the signals for two carbon 
attached to hydroxyl group, which is C-3 and C-14 that appeared at δ75.0 & 78.1.   
Compound (3). was isolated as Colorless granules. The mass spectral data of the 
compound gave a molecular weight  m/z 428. 1H NMR  spectra showed the presence 
of tow methyl’s appeared at δ 0.67 &  1.17.The proton of H-3 appeared as amultiplet 
at δ 3.67. It also showed olefinic protons at δ 5.69. 13C NMR  showed twenty one 
carbon signal including three methyles, ten methylenes, nine methins and four 
quaternary carbons. The alkenes carbons appeared at δ 166.10 & 124.23. 
Compound (4). 1H NMR spectrum showed peaks primarily in the up field region. 
However, two signals corresponding to olefinic region were observed with high 
chemical shifts values. A multiplet at δ 3.52  is characteristic to a carbinylic proton of 
sterol moiety. Peaks in low absorption field i.e., at δ 5.35 , 5.15  & 5.01  correspond to 
two and one ethylene protons respectively present on C22, C23 and C6. High 
intensity Peaks at δ 1.02 and 0.82 are corresponding to methyl groups (Me-19, Me-18, 
Me-26, Me-27 and Me-29). 13C NMR spectrum shows the presence of 6 methyl, 9 
methylene, 11 methine and 3 quaternary carbons. Signals at δ 140.86 and 121.8 
correspond to double bond. Attachment of β-hydroxyl group to C3 is visible from a 
peak at δ 71.88 [31]. High intensity peak at δ 21.21 represent angular methyl carbons 
– C19 and C18. γ-Gauche interaction enhances the screening of C-18 leading to lower 
chemical shift.  
Conclusion :- 
The isolation and identification Glochidonol, 3β,14β-dihydroxy-14β-pregn-5-en-20-
one, 3β-Hydroxystigmast-5-en-7-one  & Stigmasterol from the stems of Caralluma  
quadrangula. The work was carried out by means of various physical (solvent 
extraction, column chromatography,  radial chromatography, preparative TLC and 
malting points)  and spectral techniques 
Reference:-  
1. Rajendra Ramaswamy, Kamala, (2004). USP filed. 4: 6376657. 
2.  M. G. Gilbert, (1990). A review of Caralluma R. Br. and its segregates, 
Bradleya 8, 1- 32. 
3.  E. Abdel-Sattar, A. A. Ahmed, M. E. Hegazy, M. A. Farag, M. A. Al-Yahya, 
(2007). Acylated pregnane glycosides from Caralluma russeliana. 
Phytochemistry 68, 1459- 1463. 211. 
4.  M. Oyama, I. Iliya, T. Tanaka, M. Linuma, (2007). Five new steroidal 
glycosides from Caralluma dalzielii. Helvetica Chimica Acta 90, 63-71. 
5.  M. M. Ahmad, S. Qureshi, A. Shah, N. S. Qazi, R. M. Rao, A. M. Al-Bekairi, 
(1983). Anti-Inflammatory activity of Caralluma tuberculata alcoholic extract. 
Fitoterapia.46, 357-360. 
 6. A. R. Western, (1986).The flora of United Arab Emirates, an introduction, 
Publication of the UAE University. 
7.  M. N. Zakaria, M. W. Islam, R. Radhakrishnan, H. B. Chen, M. Kamil, A. N. 
Al-Gifri, K. Chan, A. Al-Attas, (2001). Anti-nociceptive and anti-
inflammatory properties of Caralluma arabica. J. Ethnopharmacol. 76, 155-
158. 
 
8.  Ramesh, Y. N. Rao, A. V. Rao, M. C. Prabhakar, C. S. Rao, N. Muralidhar, 
B. M. Reddy, (1998). Antinociceptive and anti-inflammatory activity of a 
flavonoid isolated from Caralluma attenuata. J. Ethnopharmacol. 62, 63-66. 
 
9.  V. M. Dembitsky, (2004). Chemistry and biodiversity of the biologically 
active natural glycosides. Chemistry & Biodiversity 1, 673-781. 
 
10.  D. S. Kumar, (2011). A medicinal plants survey for treatment of obesity. 
Journal of Pharmacy Research 4, 597-600. 
 
11. A. Bader, A.Braca, N. De Tommasi, I. Morelli, (2003). Further constituents 
from Caralluma negevensis. Phytochemistry 62, 1277-1281. 
 
12. A. Braca, A. Bader, I. Morelli, R. Carpato, G. Urchi, C. Izza, N. Tommasi, 
(2002). New pregnane glycosides from Caralluma negevensis. Tetrahedron 58, 
5837-5848. 
  
13. Malladi , Ratnakaram , Suresh Babu & Pullaiah, (2017). Phytochemical 
Investigation of Caralluma lasiantha: Isolation of Stigmasterol, an Active 
Immunomodulatory Agent. International Journal of Chemistry Sciences. 15, 
339-407. 
 
14. Vogel AI. A Text Book of Practical Organic Chemistry. 3rd edn, ELBS, 
London 1971.  
 
15.  Trease GE, Evans WC. Pharmacognosy, Saunders. Elsevier, Amsterdam, The 
Netherlands 2002;36: p.51. 
 
16. Gupta AK. Introduction to Pharmaceutics-1. CBS publication, New Delhi 
2004. 
 
17.  Harborne JB. Phytochemical methods: A guide to modern techniques of plant 
analysis. 3rd edn, Chapman and Hall, London 1998; p.302. 
